Volume 16, Number 10—October 2010
Research
Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003
Dennis E. te Beest
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. Koopmans
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. KoopmansTable 6
Risk for infection with avian influenza A (H7N7) with different levels of oseltamivir use, on the basis of serologic result as case definition, the Netherlands, 2003*
| Oseltamivir use | Risk† (95% CI) |
|---|---|
| Not used | 0.513 (0.370–0.656) |
| Not prescribed | 0.653 (0.398–0.870) |
| Prescribed but not used during visit |
0.446 (0.277–0.623) |
| Used | 0.275 (0.182–0.381) |
| Prescribed and used consistently | 0.294 (0.178–0.432) |
| Prescribed and used inconsistently | 0.281 (0.117–0.493) |
| Prescribed and consistency of use unknown |
0.181 (0.016–0.502) |
| Unknown | 0.274 (0.157–0.418) |
| Prescribed but period of use unknown | 0.274 (0.157–0.419) |
*CI, confidence interval.
†Probability of infection per visit.
